Open-label, multiple-dose, drug interaction study to assess the effect of nevirapine on the pharmacokinetics of atazanavir in HIV-infected individuals.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2011
At a glance
- Drugs Atazanavir; Atazanavir/ritonavir; Nevirapine; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- 07 Apr 2011 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 05 Feb 2007 Status changed from in progress to completed
- 15 Nov 2005 New trial record.